about
Active immunization by a dengue virus-induced cytokineEffect of adjuvants on immunization with dengue virus-induced cytotoxic factorHuman neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritisAutoantibodies induced by chimeric cytokine-HIV envelope glycoprotein immunogens.Tumor necrosis factor alpha (TNF-alpha) production in mice immunized with Escherichia coli: correlation with mortality after lethal challenge and production of a native inhibitor of TNF-alpha activityLevels of gamma interferon and interleukin-4 are inversely related to the levels of their corresponding autoantibodies in patients with lower respiratory tract infection.High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.Enhanced immunogenicity of HIV-1 envelope gp140 proteins fused to APRIL.Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA.Constitutive, but not challenge-induced, interleukin-10 production is robust in acute pre-pubescent protein and energy deficits: new support for the tolerance hypothesis of malnutrition-associated immune depression based on cytokine production in viAn expanding role for interleukin-1 blockade from gout to cancer.The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties.Scar wars strategies. Target collagen.Cytokines in inflammatory bowel disease.A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing AntibodiesSelective enhancement of the tumour necrotic activity of TNF alpha with monoclonal antibodyDepression of chemiluminescence during dengue virus infection of mice: role of cytokinesMining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymomaEffect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process.Human anti-self antibodies with high specificity from phage display libraries.Cytokines as cellular communicatorsIgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokinesDetermination of IL1 alpha, IL1 beta and IL2 in biological media using specific enzyme immunometric assays.Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.Autoantibodies against BAFF, APRIL or IL21 - an alternative pathogenesis for antibody-deficiencies?Synthesis of tumour necrosis factor-alpha and interferons by mononuclear cells from Theileria annulata-infected cattle.Binding of cytokines to pharmaceutically prepared human immunoglobulin.Is there a role for interleukin-1 blockade in intravenous immunoglobulin therapy?Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy.V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v.Ig).Immunoglobulins for intravenous use inhibit TNF alpha cytotoxicity in vitro.Modulation of autoimmune responses by intravenous immunoglobulin (IVIg).Transactivation of the interleukin-1 alpha promoter by human T-cell leukemia virus.Serum levels of interleukin-6 are not dependent on the kidney function.Anti-interleukin-6 antibodies in normal human serum.Could antibodies against serum amyloid A function as physiological regulators in humans?Cytokines, integrins and the pathogenesis of malaria.Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.Autoantibodies to cytokines.Cytokine autoantibodies in multiple sclerosis, aseptic meningitis and stroke.
P2860
Q27473449-ABEF3DBF-B85B-4A1F-98F7-0E8D50D8586AQ27473531-EE2D86A0-5FFD-415F-815D-E408295981DDQ33564182-1327BE16-810A-41C7-BE44-5BD98583232BQ33601372-DBE5C610-D03D-4E79-9374-140F1B9C08F5Q33608875-1B2B4526-02A0-4296-BC25-0A4D0FF10756Q34001214-C0E4A61E-DBC8-4487-B804-7C141CB5EA2FQ34214186-74EB95A2-CE13-47B4-9000-6BCDEB7ADB96Q34232224-86B924F3-E530-49EB-86CB-D1D0A07D4020Q34234171-92D9CE43-2D6D-46E4-8D19-52A25B50D4A1Q34566164-FA34FA7F-D892-4F2F-ACA4-3BBAF1ABAFB5Q35219001-45BD3CE9-C481-4C8E-BC3C-A2BB1D9021F1Q35292620-C7E83A22-0212-4770-A57F-36AC42C9A889Q35514544-3923C450-AF4F-4C2F-ACCA-9656EA8F7AAAQ35556914-3ED96D11-67F5-4E5C-85EE-DFBC40E325A1Q35921934-2BE9956F-0F35-4718-8E77-AA4C50C3371BQ35994055-EE247FFC-4E86-4657-981D-75BD87089BAFQ36029038-4BA3D7BB-18B7-4D72-A306-BF2608D4C5AEQ36214596-291DCAEC-0940-47A3-ADC0-13B8919B4B2AQ36363681-E0060384-E4CC-4498-B903-1A8524142ECBQ36695237-8790DA80-D6C3-4DC9-8116-D902016C48C8Q37162221-0C455EE3-E12C-470C-9A8D-0DFAF720E453Q37351068-2DEC4F25-FDBB-4ADC-8FEA-DBC8598EFA8FQ37745342-DE9BDB60-5A9F-4B0A-9BF7-D1E08E57AAF8Q37768849-865E954C-8189-4FCB-A3C6-93EF0AC0FD73Q38708467-0638D908-2921-490D-BECD-EA79BD509F05Q39368318-B5AF5D76-74A2-4CD8-83A6-B599984F2EF0Q40305824-58270600-6130-4F3F-934D-96F756AB0F0BQ40633361-CDC9F819-3BF1-4085-B599-389B5B64CA6CQ40633373-9B6DD9EB-32C0-44F2-9C5F-870CB118AF80Q40633384-07666102-E44D-424C-99E8-781236008041Q41095183-6694A8C5-37D0-46DC-AF1E-F37B47FD3729Q41589724-F9ABD515-0675-43CF-BFE5-9FA12B23BBBCQ41655886-30131423-FD1F-4B8A-909A-21AEEA41844BQ42706130-9B924DDC-40C8-4E72-BD44-570F5C581E9EQ43568331-0ACC3517-52DB-406E-A350-F05C98F244E7Q45349906-F19B1EF6-5E9D-4848-835D-162F1E995D3AQ47889076-610CA61E-6BAD-4451-82E5-3FE76C3E7195Q47973486-171FB8CB-1646-4215-9238-152E324556F1Q48005345-ACCAA983-3BB0-40FB-8B56-742A316CDAC4Q48005352-C907182F-29C4-461D-B8D1-1B379F9A8005
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Autoantibodies to cytokines--friends or foes?
@en
Autoantibodies to cytokines--friends or foes?
@nl
type
label
Autoantibodies to cytokines--friends or foes?
@en
Autoantibodies to cytokines--friends or foes?
@nl
prefLabel
Autoantibodies to cytokines--friends or foes?
@en
Autoantibodies to cytokines--friends or foes?
@nl
P2093
P1433
P1476
Autoantibodies to cytokines--friends or foes?
@en
P2093
P304
P356
10.1016/0167-5699(90)90068-K
P577
1990-05-01T00:00:00Z